SAMHSA’s Providers Clinical Support System – Medications for Opioid Use Disorder (PCSS-MOUD) is hosting a four-part learning Exchange Session that address requirements, strategies, and considerations for integrating opioid use disorder treatment in various care settings. Sessions start on August 1 and run each week through August 22 at 12 p.m. PT.
The PCSS-MOUD Exchange sessions will focus on exploring, preparing, implementing, and sustaining treatment services including the use of medications for opioid use disorder (MOUD). Topics such as medication review, patient screening, protocols, clinic workflows, and strategies for treating patients, including addressing treating patients with other heath conditions.
Exchange Session 1 – Explore on August 1, 12 – 1 p.m. PT
Review medications for opioid use disorders (MOUD), with a focus on buprenorphine treatment and its various formulations, and strategies for including harm reduction approaches into care. Discuss administrative, clinical and financial considerations, and provide resources for both prescribers and non-prescribers.
Exchange Session 2 – Prepare on August 8, 12 – 1 p.m. PT
Review patient screening considerations and discuss how OUD screening can be integrated into current clinic workflows. Discuss the training and certifications required for specific team members to implement MOUD. Highlight the critical role of Champions, and how to strategically select Champions to support MOUD implementation.
Exchange Session 3 – Implement/Sustain on August 15, 12 – 1 p.m. PT
Review considerations for MOUD initiation and follow-up, including lab guidelines, and clinical management of patients with continued use (e.g., fentanyl, novel synthetic opioids), overdose risk, poly-substance use, and comorbid mental health conditions.
Exchange Session 4 – Implement/Sustain on August 22, 12 – 1 p.m. PT
Consider approaches to sustain MOUD and ensure continued access to high-quality care for our most challenged patients, including those who are pregnant, youth/adolescents, those with acute or chronic pain, and those electing to taper their dose.
Organized by American Academy of Addiction Psychiatry, each session is a 1-hour. The sessions are designed for physicians, nurse practitioners or other advanced practice nurses, physician assistants, psychologists, licensed counselors, social workers, clinical administrators, and healthcare teams.
PCSS-MOUD is a SAMHSA funded national training, guidance, and clinical mentoring program to enhance the capacity of healthcare and counseling professionals to identify and treat opioid use disorder (OUD). PCSS-MOUD trains health professionals to provide effective, evidence-based, medication treatments to patients with opioid use disorder in primary care, psychiatric care, substance use disorder treatment, and pain management settings.
Credit Designations Available: AMA PRA Category 1 Credit™, Nursing Contact Hours, AAPA Category 1 CME credit, and Interprofessional Continuing Education (IPCE) credit. Note: A Certificate of Attendance which acknowledges 1 hour of participation is also available (0 CE).
